A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Overview of attention for article published in British Journal of Ophthalmology, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 8 X users
facebook: 1 Facebook page

guideline: 2 clinical guideline sources

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

Uveal Melanoma UK national guidelines: 2023 update

Clinical guideline published by Melanoma Focus on 05 Aug 2025

Melanoma Focus is the UK's leading melanoma charity, funding vital research to advance treatments and improve outcomes for those affected by the disease. It also provides patient support and advocates for better care.

Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline

Clinical guideline published by Cancer Care Alberta on 20 Dec 2023

Cancer Care Alberta, part of Alberta Health Services, is dedicated to providing comprehensive cancer care through compassion, courage, and innovation. They focus on detection, diagnosis, treatment, and research, aiming to support patients and families throughout their cancer journey.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.